BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30507414)

  • 1. Beyond resumption of the Japanese Government's recommendation of the HPV vaccine.
    Ueda Y; Yagi A; Ikeda S; Enomoto T; Kimura T
    Lancet Oncol; 2018 Dec; 19(12):1563-1564. PubMed ID: 30507414
    [No Abstract]   [Full Text] [Related]  

  • 2. The last strategy for re-dissemination of HPV vaccination in Japan while still under the suspension of the governmental recommendation.
    Ueda Y; Yagi A; Abe H; Nakagawa S; Minekawa R; Kuroki H; Miwa A; Kimura T
    Sci Rep; 2020 Sep; 10(1):16091. PubMed ID: 32999408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mandatory HPV vaccination and political debate.
    Gostin LO
    JAMA; 2011 Oct; 306(15):1699-700. PubMed ID: 21979129
    [No Abstract]   [Full Text] [Related]  

  • 4. HPV vaccination in Japan: what is happening in Japan?
    Ikeda S; Ueda Y; Yagi A; Matsuzaki S; Kobayashi E; Kimura T; Miyagi E; Sekine M; Enomoto T; Kudoh K
    Expert Rev Vaccines; 2019 Apr; 18(4):323-325. PubMed ID: 30768373
    [No Abstract]   [Full Text] [Related]  

  • 5. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.
    Pedersen K; Burger EA; Nygård M; Kristiansen IS; Kim JJ
    Eur J Cancer; 2018 Mar; 91():68-75. PubMed ID: 29335156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts.
    Sankaranarayanan R; Basu P; Kaur P; Bhaskar R; Singh GB; Denzongpa P; Grover RK; Sebastian P; Saikia T; Oswal K; Kanodia R; Dsouza A; Mehrotra R; Rath GK; Jaggi V; Kashyap S; Kataria I; Hariprasad R; Sasieni P; Bhatla N; Rajaraman P; Trimble EL; Swaminathan S; Purushotham A
    Lancet Oncol; 2019 Nov; 20(11):e637-e644. PubMed ID: 31674322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV vaccines: what remains to be done? Interview by Lauren Constable.
    Zur Hausen H
    Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization].
    Lazcano-Ponce E; Salmerón-Castro J; García-Carrancá A; Aranda-Flores C; Madrid-Marina V; Gómez-Altamirano CM; Martínez-Montañez OG
    Salud Publica Mex; 2009; 51(4):336-41. PubMed ID: 19668929
    [No Abstract]   [Full Text] [Related]  

  • 9. The rationale for implementation of HPV testing in routine cervical screening in Romania.
    Iancu LS; Ursu RG
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
    [No Abstract]   [Full Text] [Related]  

  • 10. Global elimination of cervical cancer is achievable-with commitment.
    The Lancet Oncology
    Lancet Oncol; 2019 Nov; 20(11):1467. PubMed ID: 31674306
    [No Abstract]   [Full Text] [Related]  

  • 11. HPV Vaccine, Especially Before Age 17, Is Associated with a Large Reduction in Invasive Cervical Cancer.
    Ebell MH
    Am Fam Physician; 2021 Mar; 103(5):312. PubMed ID: 33630552
    [No Abstract]   [Full Text] [Related]  

  • 12. HPV vaccine: implications for nurses and patients.
    Schmidt JV
    Nurs Womens Health; 2007 Feb; 11(1):83-7. PubMed ID: 17883822
    [No Abstract]   [Full Text] [Related]  

  • 13. Early impact of the Japanese immunization program implemented before the HPV vaccination crisis.
    Matsumoto K; Yaegashi N; Iwata T; Yamamoto K; Nagashima M; Saito T; Ushijima K; Takahashi F; Noda K; Yoshikawa H
    Int J Cancer; 2017 Oct; 141(8):1704-1706. PubMed ID: 28657110
    [No Abstract]   [Full Text] [Related]  

  • 14. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV vaccination strategies targeting hard-to-reach populations: Out-of-school girls in LMICs.
    Bonner K; Banura C; Basta NE
    Vaccine; 2018 Jan; 36(2):191-193. PubMed ID: 29198915
    [No Abstract]   [Full Text] [Related]  

  • 16. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus vaccination crisis in Japan.
    Dornbusch HJ; Stiris T; Del Torso S; Ross-Russell R; Zavrsnik J; Wettergren B; Mercier JC; Valiulis A; Hadjipanayis A
    J Paediatr Child Health; 2015 Dec; 51(12):1146-7. PubMed ID: 26633608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccines: WHO position paper, May 2017.
    Wkly Epidemiol Rec; 2017 May; 92(19):241-68. PubMed ID: 28530369
    [No Abstract]   [Full Text] [Related]  

  • 19. Time to resume active recommendation of the HPV vaccine in Japan.
    Tanaka Y
    Lancet Oncol; 2020 Dec; 21(12):1552-1553. PubMed ID: 33271087
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer prevention or parents' rights?
    Hawks JH
    Urol Nurs; 2007 Apr; 27(2):110-1. PubMed ID: 17500100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.